Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)
Alcon announced its intention to acquire LumiThera and its PBM device for the treatment of…
Alcon Canada Earns Global Recognition as a Top Employer
Alcon announced that Alcon Canada has been certified as a Top Employer in Canada by…
Alcon Acquires Majority Interest in Aurion Biotech, to Advance Innovative Cell Therapy for Corneal Endothelial Disease
Alcon announced it has acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced…